Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The benefits of validation of methods for toxicity testing outweigh its costs

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development (OCDE); PEPPER; Vrije Universiteit Amsterdam Amsterdam (VU); Joint Clinical Research Centre; Direction de l'Evaluation des Risques (DER); Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES)
    • بيانات النشر:
      HAL CCSD
      Elsevier
    • الموضوع:
      2024
    • Collection:
      Anses: HAL (Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail)
    • نبذة مختصرة :
      International audience ; The 4th Annual Forum on Endocrine Disrupters organized by the European Commission brought together authors of this article around the topic: "From bench to validated test guidelines: (pre)validation of test methods". Validation activities are meant to demonstrate the relevance and reliability of methods and approaches used in regulatory safety testing. These activities are essential to facilitate regulatory use, still they are largely underfunded and unattractive to the scientific community. In the last decade, there has been large amounts of funding invested in European research towards the development of approaches that can be used in regulatory decision-making, including for the identification of endocrine disrupters. There is a vast pool of candidate test methods for potential regulatory applications, but most of them will not be used due to the absence of consideration of their relevance and reliability outside the method developer's laboratory. The article explains the reasons why such a gap exists between the outputs of research projects and the uptake in a regulatory context. In parallel, there are also increasing expectations from the regulatory science community that validation becomes more efficient with respect to time and resources. This article shares some of the lessons learned and proposes paths forward for validation of new methods that are not intended as one-to-one replacements of animal studies. This includes submitting only mature methods for validation that were developed following good practices and good documentation, proposing a greater emphasis on well-documented transferability studies, and adopting a cost-sharing model between those who benefit from validated methods.
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/38501278; anses-04627760; https://anses.hal.science/anses-04627760; https://anses.hal.science/anses-04627760v1/document; https://anses.hal.science/anses-04627760v1/file/Gourmelon_Altex_2024.pdf; PUBMED: 38501278
    • الرقم المعرف:
      10.14573/altex.2403051
    • الدخول الالكتروني :
      https://anses.hal.science/anses-04627760
      https://anses.hal.science/anses-04627760v1/document
      https://anses.hal.science/anses-04627760v1/file/Gourmelon_Altex_2024.pdf
      https://doi.org/10.14573/altex.2403051
    • Rights:
      http://creativecommons.org/licenses/by/ ; info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.529E3032